BeyondMedicine Demonstrates Clickless at DENTEX 2027
The event takes place on January 24, 2027, on the third floor of COEX Hall D, running from 9:30 a.m. to 6 p.m.
Clickless operates as a software medical device prescribed by dentists. Patients complete a six-week regimen consisting of exercise therapy, relaxation programs based on cognitive behavioral therapy, behavioral habit tracking, pain logging, and educational materials. The software functions entirely via smartphone without requiring external sensors or wearable hardware.
BeyondMedicine Secured Medical Device Approval for Self-Management Programs
The application allows patients to perform self-management programs outside of clinical settings. Meanwhile, medical staff can review program completion status and symptom changes to guide future consultations.
BeyondMedicine secured approval as a medical device item from the Ministry of Food and Drug Safety in December 2025, followed by designation as a provisional new medical technology assessment subject. According to company disclosures, these regulatory milestones permit non-reimbursable prescription options based on applicable procedures and conditions.
The company obtained clinical evidence supporting pain reduction and functional improvement through a multi-center randomized controlled trial. BeyondMedicine representatives stated that the upcoming exhibition will feature live demonstrations of the prescription workflow, the patient application, and clinician management tools.
“Clickless is a digital therapeutic that connects dental practice with patients’ daily self-care,” a BeyondMedicine representative stated, according to dtissue.com. “We plan to introduce the actual prescription process and patient management functions at this DENTEX 2027, and present concrete operation plans that can be utilized in private practices.”
BeyondMedicine Will Expand Prescription Dental Networks and Accessibility
Booth activities will introduce patient guidance and operational strategies for private dental clinics, alongside prescription dental registration and product demonstrations.
“We will expand the prescription dental network and increase patients’ digital therapy accessibility to provide a new option for temporomandibular disorder management,” the BeyondMedicine representative added, dtissue.com reported.
Product inquiries are directed to BeyondMedicine, while event logistics are handled by the DENTEX 2027 secretariat.
Seek Medical Evaluation for Jaw Locking or Systemic Fever
Patients experiencing sudden jaw locking, localized swelling, systemic fever, or acute trauma should seek immediate in-person evaluation by a licensed dental or medical professional rather than relying solely on smartphone-based self-management interventions.
References
- Ministry of Food and Drug Safety (MFDS). Medical Device Approval Database and Regulatory Framework for Software as a Medical Device (SaMD).
- DENTEX 2027 Organizing Committee. Exhibition Overview and Program Schedule. Seoul, Korea.
